Mobile

A randomized, double-blind, placebo-controlled, multi-center, parallel group study to assess the efficacy of vardenafil in the treatment of symtomatic Benign Prostatic Hyperplasia

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002796-32

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the efficacy, tolerability and safety of vardenafil (10 mg BID) versus placebo in the two month treatment of men with symptomatic BPH.

Critère d'inclusion

  • Benigne Prostatic Hyperplasia

Liens